Open AccessP1456: EARLY SAFETY AND CLINICAL COURSE OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MEASURABLE RESIDUAL DISEASE RECEIVING GTA002, AN OFF‐THE‐SHELF, EX VIVO‐CULTURED ALLOGENEIC NK CELL PREPARATION
Author(s) -
Heuser M.,
Fiedler W.,
Block A.,
Leeuw D. C.,
Loosdrecht A.,
Astrid TschanPlessl A.,
Passweg J.,
Kloos A.,
Schwarzer A.,
Venturini L.,
Duru A. D.,
Pinkernell K.,
Ganser A.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000848680.66640.98
Subject(s) - medicine , fludarabine , minimal residual disease , myeloid leukemia , cumulative incidence , transplantation , cyclophosphamide , hematopoietic stem cell transplantation , umbilical cord , oncology , cord blood , leukemia , stem cell , gastroenterology , immunology , chemotherapy , biology , genetics